Name | SIQ17 |
---|
Description | SIQ17 is an EGFR inhibitor that inhibits its activity by occupying the ATP-binding site, with IC50 of 0.62 nM. SIQ17 shows more effective EGFR-TK inhibitory activity compared to the known inhibitor Erlotinib (HY-50896) (IC50 of ∼20 nM). SIQ17 can be used for cancer research[1] |
---|---|
Related Catalog | |
References |
Molecular Formula | C32H27NO2S |
---|---|
Molecular Weight | 489.63 |